SCHEMBL12447948

SCHEMBL12447948

O=C(C1CCCC1)N1CC[C@@H](c2ccccc2)C1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 3/20 0.61
RAB9A P51151 6/20 0.60
NPC1 O15118 5/20 0.60
SMN1; SMN2 Q16637 4/20 0.60
TP53 P04637 2/20 0.60
ALDH1A1 P00352 1/20 0.60
POLB P06746 1/20 0.60
MAPT P10636 3/20 0.57
ATM Q13315 1/20 0.57
HPGD P15428 1/20 0.57
ADAM10 O14672 1/20 0.54
ERBB2 P04626 1/20 0.54
LMNA P02545 1/20 0.53
NFKB1 P19838 1/20 0.53
NFKB2 Q00653 1/20 0.53
RELA Q04206 1/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
RIPK1 Q13546 1/20 0.53
HSD11B1 P28845 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12447336 0.97 CCR5 (0.61) CCR5RAB9ANPC1SMN1; SMN2TP53
SCHEMBL12447952 0.95 RAB9A (0.61) CCR5RAB9ANPC1SMN1; SMN2TP53
SCHEMBL12447717 0.88 NAMPT (0.57) CCR5RAB9ANPC1SMN1; SMN2TP53
SCHEMBL11178698 0.87 ALDH1A1 (0.58) CCR5RAB9ANPC1SMN1; SMN2TP53
SCHEMBL19988362 0.85 HTR2B (0.64) CCR5RAB9ANPC1SMN1; SMN2TP53
SCHEMBL3184817 0.83 RAB9A (0.67) RAB9ANPC1SMN1; SMN2TP53ALDH1A1
SCHEMBL27842786 0.83 RAB9A (0.67) RAB9ANPC1SMN1; SMN2TP53ALDH1A1
SCHEMBL3183827 0.83 RAB9A (0.67) RAB9ANPC1SMN1; SMN2TP53ALDH1A1
SCHEMBL3183837 0.83 RAB9A (0.67) RAB9ANPC1SMN1; SMN2TP53ALDH1A1
SCHEMBL10143901 0.80 SIGMAR1 (0.67) RAB9ANPC1SMN1; SMN2TP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786815-B1 SPIRO COMPOUNDS AND METHODS FOR THE MODULATION OF CHEMOKINE RECEPTOR ACTIVITY VIROCHEM PHARMA INC (CA) 2011-08-24 EP disclosed
WO-2009092293-A1 PYROLLIDINE-BASED COMPOUNDS SHANGHAI TARGETDRUG CO., LTD. (CN) 2009-07-30 WO disclosed
WO-2009089659-A1 PYROLLIDINE-BASED COMPOUNDS SHANGHAI TARGETDRUG CO., LTD. (CN) 2009-07-23 WO disclosed